RN7SL333P

Across TCGA pan-cancer cohorts, RN7SL333P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RN7SL333P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RN7SL333P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL333P is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

STAD, BLCA, and KIRC are the cancer types where RN7SL333P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL333P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.427	.001	9	view →
BLCA	All	All	+0.544	.008	5	view →
KIRC	All	All	+0.275	<.001	5	view →
LUSC	Male	All	+0.361	.010	4	view →
CHOL	All	All	+1.060	.018	3	view →
LUAD	Male	All	+0.574	.003	2	view →
LIHC	Male	All	+0.381	<.001	2	view →
BRCA	All	II,III,IV	+0.258	.028	2	view →
PRAD	All	All	+0.223	.027	2	view →
KICH	All	All	−0.205	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RN7SL333P–STAD

Open the STAD breakdown →